Vista Partners Updates Coverage on Mast Therapeutics, Inc.; Price Target $2.25
18. Juli 2013 09:15 ET
|
Vista Partners LLC
SAN FRANCISCO, CA--(Marketwired - Jul 18, 2013) - Vista Partners announced today that it has updated coverage on Mast Therapeutics Inc. (NYSE MKT: MSTX) ("MSTX"), a publicly traded...